Anesthetic drugs & techniques

Comparison of recovery profiles between total intravenous anaesthesia with propofol or remimazolam reversed with flumazenil in patients undergoing breast surgery: A randomised controlled trial

Eur J AnaesthesiolPublished Randomised controlled trial

Authors' conclusion

Administration of remimazolam with flumazenil may be a promising option for patients undergoing breast cancer surgery, providing faster recovery and better SAS scores than propofol during emergence from general anaesthesia.

Study context

Population
Adults (≥19 years) undergoing GA for scheduled breast cancer surgery, tertiary teaching hospital, South Korea, August–December 2022
Comparison
Remimazolam reversed with flumazenil vs propofol TIVA
Primary endpoint
Time to eye opening to command during recovery from GA
Methodological detailssingle-centre, double-blind, Emergence monitored by only one anaesthesiologist
  • Single-centre
  • Double-blind
  • Emergence monitored by only one anaesthesiologist

Primary result

Time to eye opening to command

Mean difference

187 s

95% CI 133–241

P < 0.001

By group

Remimazolam vs Propofol
mean difference 187 s (95% CI 133–241); P < 0.001

As reported in the abstract

Secondary outcomes

Mean, s

OutcomePropofolMean difference (s) (95% CI)P value
Time to SGA removalRemimazolam vs Propofol366 (SD 149)198 (140–255)P < 0.001
Time to discharge from the operating roomRemimazolam vs Propofol449 (SD 159)206 (145–267)P < 0.001
OutcomePropofolP value
Riker SAS score 4 during emergenceRemimazolam vs Propofol · SAS scores differed significantly1 eventsP < 0.001
  • Time to supraglottic airway (SGA) removal: Remimazolam mean 169 (SD 51) s
  • Time to discharge from the operating room: Remimazolam mean 243 (SD 55) s
  • Riker sedation agitation scale (SAS) score 4 during emergence: Remimazolam 25 events

Original publication

Comparison of recovery profiles between total intravenous anaesthesia with propofol or remimazolam reversed with flumazenil in patients undergoing breast surgery: A randomised controlled trial. Eur J Anaesthesiol. Published 11 January 2024. doi:10.1097/eja.0000000000001951

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.